A phase 3 trial of inotuzumab ozogamicin for high-risk B-ALL: Second safety phase results from Children's Oncology Group AALL1732

被引：0
|
作者：
O'Brien, Maureen Megan
McNeer, Jennifer Lynn
Rheingold, Susan R.
Devidas, Meenakshi
Chen, Zhiguo
Bhojwani, Deepa
Ramsey, Laura B.
Agrawal, Anurag
Wood, Brent L.
Suh, Eugene
Alexander, Sarah
Miller, Tamara P.
Militano, Olga
Burke, Michael
Salzer, Wanda L.
Raetz, Elizabeth A.
Loh, Mignon L.
机构：
[1] Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH USA
[2] Univ Chicago, Chicago, IL USA
[3] Childrens Hosp Philadelphia, Philadelphia, PA USA
[4] St Jude Childrens Res Hosp, Memphis, TN USA
[5] Univ Florida, Dept Biostat, Gainesville, FL USA
[6] Childrens Hosp Los Angeles, Los Angeles, CA USA
[7] UCSF, Benioff Childrens Hosp Oakland, Oakland, CA USA
[8] CHLA, Los Angeles, CA USA
[9] Loyola Univ, Med Ctr, Maywood, IL USA
[10] Hosp Sick Children, Toronto, ON, Canada
[11] Emory Univ, Atlanta, GA USA
[12] Childrens Oncol Grp, Monrovia, CA USA
[13] Med Coll Wisconsin, Milwaukee, WI USA
[14] Uniformed Serv Univ Hlth Sci, Bethesda, MD USA
[15] Perlmutter Canc Ctr, New York, NY USA
[16] NYU Langone, New York, NY USA
[17] Seattle Childrens Hosp, Seattle, WA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
基金：
美国国家卫生研究院;
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
10016
引用
收藏
页数：1
相关论文
共 50 条
  • [41] A safety and feasibility trial of 131I-MIBG in newly diagnosed high-risk neuroblastoma: A Children's Oncology Group study
    Weiss, Brian D.
    Yanik, Gregory
    Naranjo, Arlene
    Zhang, Fan F.
    Fitzgerald, Wendy
    Shulkin, Barry L.
    Parisi, Marguerite T.
    Russell, Heidi
    Grupp, Stephan
    Pater, Luke
    Mattei, Peter
    Mosse, Yael
    Lai, Hollie A.
    Jarzembowski, Jason A.
    Shimada, Hiroyuki
    Villablanca, Judith G.
    Giller, Roger
    Bagatell, Rochelle
    Park, Julie R.
    Matthay, Katherine K.
    PEDIATRIC BLOOD & CANCER, 2021, 68 (10)
  • [42] Dexamethasone and High-Dose Methotrexate Improve Outcome for Children and Young Adults With High-Risk B-Acute Lymphoblastic Leukemia: A Report From Children's Oncology Group Study AALL0232
    Larsen, Eric C.
    Devidas, Meenakshi
    Chen, Si
    Salzer, Wanda L.
    Raetz, Elizabeth A.
    Loh, Mignon L.
    Mattano, Leonard A., Jr.
    Cole, Catherine
    Eicher, Alisa
    Haugan, Maureen
    Sorenson, Mark
    Heerema, Nyla A.
    Carroll, Andrew A.
    Gastier-Foster, Julie M.
    Borowitz, Michael J.
    Wood, Brent L.
    Willman, Cheryl L.
    Winick, Naomi J.
    Hunger, Stephen P.
    Carroll, William L.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (20) : 2380 - U129
  • [43] Outcomes in CCG-2961, a Children's Oncology Group Phase 3 Trial for untreated pediatric acute myeloid leukemia: a report from the Children's Oncology Group
    Lange, Beverly J.
    Smith, Franklin O.
    Feusner, James
    Barnard, Dorothy R.
    Dinndorf, Patricia
    Feig, Stephen
    Heerema, Nyla A.
    Arndt, Carola
    Arceci, Robert J.
    Seibel, Nita
    Weiman, Margie
    Dusenbery, Kathryn
    Shannon, Kevin
    Luna-Fineman, Sandra
    Gerbing, Robert B.
    Alonzo, Todd A.
    BLOOD, 2008, 111 (03) : 1044 - 1053
  • [44] REINDUCTION WITH BLINATUMOMAB ALONE OR WITH NIVOLUMAB FOR FIRST RELAPSE OF B-ACUTE LYMPHOBLASTIC LEUKEMIA: RESULTS FROM GROUP 1 OF THE CHILDREN'S ONCOLOGY GROUP TRIAL AALL1821
    Cooper, Stacy
    Ji, Lingyun
    Bhojwani, Deepa
    Breese, Erin
    Van Huynh
    Maude, Shannon
    Raetz, Elizabeth
    Verma, Anupam
    Xi, Xinxin
    Borowitz, Michael
    Teachey, David
    Brown, Patrick
    Loh, Mignon
    PEDIATRIC BLOOD & CANCER, 2023, 70 : S99 - S99
  • [45] Toxicity associated with intensive postinduction therapy incorporating clofarabine in the very high-risk stratum of patients with newly diagnosed high-risk B-lymphoblastic leukemia: A report from the Children's Oncology Group study AALL1131
    Salzer, Wanda L.
    Burke, Michael J.
    Devidas, Meenakshi
    Chen, Si
    Gore, Lia
    Larsen, Eric C.
    Borowitz, Michael
    Wood, Brent
    Heerema, Nyla A.
    Carroll, Andrew J.
    Hilden, Joanne M.
    Loh, Mignon L.
    Raetz, Elizabeth A.
    Winick, Naomi J.
    Carroll, William L.
    Hunger, Stephen P.
    CANCER, 2018, 124 (06) : 1150 - 1159
  • [46] The impact of initial cerebrospinal fluid (CSF) findings on outcome among patients with NCI standard (SR) and high-risk (HR) B-lymphoblastic leukemia (ALL): A report from the Children's Oncology Group (COG) Studies AALL0331 and AALL0232.
    Winick, Naomi Joan
    Devidas, Meenakshi
    Maloney, Kelly W.
    Larsen, Eric
    Mattano, Leonard A.
    Borowitz, Michael J.
    Carroll, Andrew J.
    Gastier-Foster, Julie M.
    Heerema, Nyla A.
    Willman, Cheryl L.
    Wood, Brent L.
    Loh, Mignon L.
    Raetz, Elizabeth A.
    Hunger, Stephen
    Carroll, William L.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [47] OSTEONECROSIS IS ASSOCIATED WITH IMPROVED EVENT FREE (EFS) AND OVERALL SURVIVAL (OS) IN HIGH-RISK ACUTE LYMPHOBLASTIC LEUKEMIA (HR-ALL): RESULTS OF CHILDREN'S ONCOLOGY GROUP (COG) STUDY AALL0232
    Mattano, Leonard
    Devidas, Meenakshi
    Chen, Si
    Raetz, Elizabeth
    Loh, Mignon
    Winick, Naomi
    Hunger, Stephen
    Carroll, William
    Larsen, Eric
    PEDIATRIC BLOOD & CANCER, 2018, 65
  • [48] A phase II window trial of procarbazine and topotecan in children with high-grade glioma: a report from the children’s oncology group
    Murali M. Chintagumpala
    Henry S. Friedman
    Clinton F. Stewart
    James Kepner
    Roger E. McLendon
    Paul L. Modrich
    Charles McCluggage
    Peter Burger
    Emi Holmes
    Stephen Thompson
    James Rutka
    Jeff Michalski
    Shiao Woo
    Susan M. Blaney
    Larry E. Kun
    and Marc E. Horowitz
    Journal of Neuro-Oncology, 2006, 77 : 193 - 198
  • [49] Patterns of Relapse from a Phase 3 Study of Response-Based Therapy for High-Risk Hodgkin Lymphoma (AHOD0831): A Report from the Children's Oncology Group
    Parikh, R. R.
    Hoppe, B. S.
    Hodgson, D.
    McCarten, K. M.
    Pei, Q.
    Cho, S. Y.
    Schwartz, C.
    Cole, P.
    Kelly, K. M.
    Roberts, K. B.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : S36 - S37
  • [50] A phase II window trial of procarbazine and topotecan in children with high-grade glioma: a report from the children's oncology group
    Chintagumpala, Murali M.
    Friedman, Henry S.
    Stewart, Clinton F.
    Kepner, James
    McLendon, Roger E.
    Modrich, Paul L.
    McCluggage, Charles
    Burger, Peter
    Holmes, Emi
    Thompson, Stephen
    Rutka, James
    Michalski, Jeff
    Woo, Shiao
    Blaney, Susan M.
    Kun, Larry E.
    Horowitz, Marc E.
    JOURNAL OF NEURO-ONCOLOGY, 2006, 77 (02) : 193 - 198
12345